LAP (NF-IL-6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation - PubMed (original) (raw)

LAP (NF-IL-6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation

M Buck et al. EMBO J. 1994.

Abstract

During postnatal liver development, LAP (NF-IL-6, C/EBP beta) expression and hepatocyte proliferation are mutually exclusive. In addition to transactivating liver-specific genes, LAP, but not C/EBP alpha, arrests the cell cycle before the G1/S boundary in hepatoma cells. LIP, a liver-inhibitory protein, which is translated from LAP mRNA lacking the activation domain of LAP, is not only ineffective in blocking hepatoma cell proliferation but also antagonizes the effect of LAP on the cell cycle. Deletion analysis indicated that this effect of LIP required only the DNA-binding and leucine zipper domains. In addition we found that integrity of the LAP dimerization and activation domains is indispensable for the arrest of cell proliferation induced by LAP. Thus, hepatocyte differentiation and its characteristic quiescent state may be modulated by the LAP/LIP ratio.

PubMed Disclaimer

Similar articles

• The DNA binding activity of C/EBP transcription factor is regulated in the G1 phase of the hepatocyte cell cycle.
  Rana B, Xie Y, Mischoulon D, Bucher NL, Farmer SR. Rana B, et al. J Biol Chem. 1995 Jul 28;270(30):18123-32. doi: 10.1074/jbc.270.30.18123. J Biol Chem. 1995. PMID: 7629124
• C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver.
  Luedde T, Duderstadt M, Streetz KL, Tacke F, Kubicka S, Manns MP, Trautwein C. Luedde T, et al. Hepatology. 2004 Aug;40(2):356-65. doi: 10.1002/hep.20333. Hepatology. 2004. PMID: 15368440
• C/EBP-beta/LAP controls down-regulation of albumin gene transcription during liver regeneration.
  Trautwein C, Rakemann T, Pietrangelo A, Plümpe J, Montosi G, Manns MP. Trautwein C, et al. J Biol Chem. 1996 Sep 6;271(36):22262-70. doi: 10.1074/jbc.271.36.22262. J Biol Chem. 1996. PMID: 8703043
• Glucocorticoid-stimulated CCAAT/enhancer-binding protein alpha expression is required for steroid-induced G1 cell cycle arrest of minimal-deviation rat hepatoma cells.
  Ramos RA, Nishio Y, Maiyar AC, Simon KE, Ridder CC, Ge Y, Firestone GL. Ramos RA, et al. Mol Cell Biol. 1996 Oct;16(10):5288-301. doi: 10.1128/MCB.16.10.5288. Mol Cell Biol. 1996. PMID: 8816441 Free PMC article.

Cited by

• Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma.
  Krivtsova O, Makarova A, Lazarevich N. Krivtsova O, et al. World J Hepatol. 2018 Oct 27;10(10):645-661. doi: 10.4254/wjh.v10.i10.645. World J Hepatol. 2018. PMID: 30386458 Free PMC article. Review.
• CCAAT/enhancer-binding protein-β functions as a negative regulator of Wnt/β-catenin signaling through activation of AXIN1 gene expression.
  Park S, Lee MS, Gwak J, Choi TI, Lee Y, Ju BG, Kim CH, Oh S. Park S, et al. Cell Death Dis. 2018 Oct 3;9(10):1023. doi: 10.1038/s41419-018-1072-1. Cell Death Dis. 2018. PMID: 30283086 Free PMC article.
• Liver-enriched activator protein 1 as an isoform of CCAAT/enhancer-binding protein beta suppresses stem cell features of hepatocellular carcinoma.
  Yang LH, Wang Y, Qiao S, Wang MJ, Chen F, Zi XY, Li JX, Zhang HB, Yu B, Hu YP. Yang LH, et al. Cancer Manag Res. 2018 Apr 26;10:873-885. doi: 10.2147/CMAR.S160172. eCollection 2018. Cancer Manag Res. 2018. PMID: 29731667 Free PMC article.
• TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer.
  Meyer RD, Zou X, Ali M, Ersoy E, Bondzie PA, Lavaei M, Alexandrov I, Henderson J, Rahimi N. Meyer RD, et al. Oncotarget. 2017 Dec 26;9(11):9672-9684. doi: 10.18632/oncotarget.23822. eCollection 2018 Feb 9. Oncotarget. 2017. PMID: 29515762 Free PMC article.

References

1. 1. Cell. 1989 Jun 30;57(7):1179-87 - PubMed
2. 1. Genes Dev. 1991 Sep;5(9):1553-67 - PubMed
3. 1. Science. 1990 Aug 31;249(4972):1049-51 - PubMed
4. 1. Genes Dev. 1991 Oct;5(10):1754-66 - PubMed
5. 1. Science. 1989 Nov 17;246(4932):911-6 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program